LoginRegister
    Boehringer collaborates with MD Anderson to form virtual RnD center to advance new cancer therapiesBoehringer collaborates with MD Anderson to form virtual RnD center to advance new cancer therapies
    2 dead, 1 injured after fire engulfed Aurobindo Pharma power plant in Andhra Pradesh2 dead, 1 injured after fire engulfed Aurobindo Pharma power plant in Andhra Pradesh
    Natco Pharma gets 6 USFDA observations for API facility near HyderabadNatco Pharma gets 6 USFDA observations for API facility near Hyderabad
    Unichem Labs wins USFDA nod for pain management drug Tramadol Hydrochloride tabletsUnichem Labs wins USFDA nod for pain management drug Tramadol Hydrochloride tablets
    Indoco Remedies successfully completes USFDA inspection of CRO Anacipher in HyderabadIndoco Remedies successfully completes USFDA inspection of CRO Anacipher in Hyderabad
    Eli Lilly Vs Dr Reddys, Hospira: Court rules in favour of Lilly in Alimta alternate salt form patent lawsuitEli Lilly Vs Dr Reddys, Hospira: Court rules in favour of Lilly in Alimta alternate salt form patent...
    US Senate seeks information on Novartis $2 million Zolgensma data issuesUS Senate seeks information on Novartis $2 million Zolgensma data issues
    Unichem Laboratories gets USFDA nod to market BP drug Chlorthalidone tabletUnichem Laboratories gets USFDA nod to market BP drug Chlorthalidone tablet
    CK Birla Hospital for Women to invest up to Rs 1,000 cr, add 14 hospitals by end of 2025CK Birla Hospital for Women to invest up to Rs 1,000 cr, add 14 hospitals by end of 2025
    Divis Labs Chairman C Murali K Divi highest paid Indian pharma executive, Check out his RemunerationDivis Labs Chairman C Murali K Divi highest paid Indian pharma executive, Check out his Remuneration
    Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC NannapaneniNatco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni
    Ex-Eagle Scout accused in online drug empire to stand trialEx-Eagle Scout accused in online drug empire to stand trial
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X